Form 497 LAZARD FUNDS INC
Tweet
Share
E-mailTHE LAZARD FUNDS, INC.
All Portfolios
Supplement to Current Prospectus
The following is added as the last paragraph of "Fund Management—Investment Manager" in the Prospectus and supersedes and replaces any contrary information:
In addition, to the extent the Total Annual Portfolio Operating Expenses of the R6 Shares of a Portfolio exceed the Total Annual Portfolio Operating Expenses of the Portfolio's Institutional Shares (in each case, not including management fees, custodial fees or other expenses related to the management of the Portfolio's assets), the Investment Manager has contractually agreed, until May 1, 2017, to bear the expenses of the R6 Shares in the amount of such excess. This agreement will terminate automatically in the event of termination of the Management Agreement between the Investment Manager and the Fund, on behalf of the Portfolio.
Dated: November 9, 2016
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Century Therapeutics (IPSC) to Acquire Clade Therapeutics, Announces $60M Private Placement
- Lazard (LAZ) Reports March 2024 Assets Under Management
- Vertex (VRTX) Enters Into Agreement to Acquire Alpine Immune Sciences (ALPN)
Create E-mail Alert Related Categories
SEC FilingsRelated Entities
LazardSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
